Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults
Clinical trial NCT02034500 · COMPLETED
Trial details
- NCT number
- NCT02034500
- Sponsor
- GSK Vaccines Institute For Global Health S.r.l.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-04-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.